Telomerase and telomere inhibitors in

Author： Sharma S. Raymond E. Soda H. von Hoff D.D.

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.6, Iss.9, 1997-09, pp. : 1179-1186

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of telomerase inhibitors

By Rowley Peter T

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 12, 2001-12 ,pp. : 1815-1823

Informa Healthcare

Access to resources Recommend Favorite

Design of Telomerase Inhibitors for the Treatment of Cancer

Current Pharmaceutical Design, Vol. 8, Iss. 27, 2002-12 ,pp. : 2491-2504

Bentham Science Publishers

Access to resources Recommend Favorite

Telomerase inhibition and telomere erosion: a two-pronged strategy in cancer therapy

By Odago F.O. Gerson S.L.

Trends in Pharmacological Sciences, Vol. 24, Iss. 7, 2003-07 ,pp. : 328-331

Elsevier

Access to resources Recommend Favorite

Telomerase inhibitors for the treatment of cancer: the current perspective

By Perry Philip J Arnold John RP Jenkins Terence C

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 12, 2001-12 ,pp. : 2141-2156

Informa Healthcare

Access to resources Recommend Favorite

Recent advances in the development of telomerase inhibitors for the treatment of cancer

By Perry P.J. Jenkins T.C.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 12, 1999-12 ,pp. : 1981-2008

Informa Healthcare

Access to resources Recommend Favorite